|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
$41,335
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
$374
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
$1,224
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$1,491
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$1,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$116,025
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
Understanding Variation in Radioactive Iodine Use in Treatment of Thyroid Cancer
|
5K07CA154595-03
|
$167,096
|
$167,096
|
Haymart, Megan
|
UNIVERSITY OF MICHIGAN
|
|
TXNIP as a regulator of thyroid cancer aggressiveness
|
1F32CA174374-01
|
$59,432
|
$59,432
|
Morrison, Jennifer
|
UNIVERSITY OF COLORADO DENVER
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
1R01CA175994-01
|
$320,329
|
$320,329
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$192,735
|
$5,782
|
Merino, Maria
|
CCR (NCI)
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$385,381
|
$385,381
|
Kimura, Shioko
|
CCR (NCI)
|
|
Thyroid Cell Signaling: Targeting Src and BRAF
|
1F32CA177282-01
|
$49,214
|
$49,214
|
Vanden Borre, Pierre
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Thyroid Cancer among Chornobyl Clean-up Workers in Ukraine: Pilot Study
|
ZIA CP010133-10531
|
$173,510
|
$173,510
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$883,391
|
$441,696
|
Kebebew, Electron
|
CCR (NCI)
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
1R01CA178007-01
|
$351,713
|
$351,713
|
Jin, Moonsoo
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The Role of BRAF Mutation in Thyroid Cancer Invasion
|
5R01CA149738-03
|
$301,154
|
$301,154
|
Parangi, Sareh
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
1P50CA168505-01A1
|
$2,150,500
|
$2,150,500
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
|
5R01CA155512-03
|
$290,901
|
$290,901
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
The Chernobyl Tissue Bank - Coordinating Center
|
4U24CA082102-13
|
$242,127
|
$242,127
|
Thomas, Geraldine
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$44,243
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Targeting Focal Adhesion Kinase in Thyroid Cancer
|
5R01CA164193-02
|
$299,226
|
$299,226
|
Schweppe, Rebecca
|
UNIVERSITY OF COLORADO DENVER
|
|
Studies in the Janus Cohort
|
ZIA CP010120-02135
|
$72,896
|
$6,561
|
Rothman, Nat
|
DCEG (NCI)
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$237,100
|
$11,855
|
Rothman, Nat
|
DCEG (NCI)
|
|
Role of Skp2-cyclin A Interaction in Normal Physiology and Cancer
|
5R01CA131421-05
|
$282,663
|
$141,332
|
ZHU, LIANG
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010219-10447
|
$120,876
|
$120,876
|
Berrington, Amy
|
DCEG (NCI)
|
|
RhoB in cancer pathogenesis and as a target in combinatorial therapy
|
5R01CA136665-04
|
$293,662
|
$293,662
|
COPLAND, JOHN
|
MAYO CLINIC JACKSONVILLE
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-05
|
$139,821
|
$6,991
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Regional Oncology Research Center
|
3P30CA006973-50S1
|
$43,750
|
$875
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-50S2
|
$50,000
|
$1,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-50
|
$6,540,575
|
$130,812
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
RCAN1 in Thyroid Cancer Progression
|
5R01CA152066-03
|
$313,545
|
$313,545
|
Ringel, Matthew
|
OHIO STATE UNIVERSITY
|
|
Rap1Gap and Tumor Progression
|
5R01CA127986-05
|
$302,718
|
$302,718
|
MEINKOTH, JUDY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Radiation and molecular and genetic studies of thyroid cancer
|
ZIA CP010132-10650
|
$4,439
|
$4,439
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,539,189
|
$76,959
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$477,918
|
$382,334
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Pooled analysis of radiation-related thyroid cancer
|
ZIA CP010222-10430
|
$23,809
|
$23,809
|
Sigurdson, Alice
|
DCEG (NCI)
|
|
PKA and follicular thyroid carcinogenesis: Roles of interacting pathways
|
1R01CA170249-01A1
|
$316,438
|
$316,438
|
KIRSCHNER, LAWRENCE
|
OHIO STATE UNIVERSITY
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
1R01CA167839-01A1
|
$346,525
|
$346,525
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer
|
5R01CA151842-04
|
$294,031
|
$294,031
|
KOENIG, RONALD
|
UNIVERSITY OF MICHIGAN
|
|
Papillary thyroid cancer and tumor-associated macrophages
|
7K08CA133183-04
|
$165,780
|
$165,780
|
Ryder, Mabel
|
MAYO CLINIC ROCHESTER
|
|
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer
|
1R44CA171352-01A1
|
$283,958
|
$283,958
|
Weintraub, Bruce
|
TROPHOGEN, INC.
|
|
Molecular Pathophysiology of Thyroid Cell Growth
|
5R01CA050706-23
|
$368,104
|
$368,104
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RES
|
|
Molecular Events in the PI3K/Akt Pathway in Thyroid Cancer
|
5R01CA134225-05
|
$310,286
|
$310,286
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Microfluidic Chip for Genome Analysis
|
5R21CA168345-02
|
$187,715
|
$93,858
|
WEIER, HEINZ-ULRICH
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Metastatic protein network in BRAFV600E positive human thyroid cancers
|
5R21CA165039-02
|
$142,297
|
$142,297
|
Nucera, Carmelo
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,497,257
|
$224,863
|
Fojo, Antonio
|
CCR (NCI)
|
|
Mechanisms of RET/PTC Rearrangement in Thyroid Cancer
|
2R01CA088041-11A1
|
$257,486
|
$257,486
|
NIKIFOROV, YURI
|
UNIVERSITY OF PITTSBURGH
|
|
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
|
1R01CA173592-01A1
|
$414,552
|
$414,552
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RES
|
|
Iowa Womens Health Study Drinking Water Nitrate Analysis
|
ZIA CP010125-10347
|
$25,617
|
$2,562
|
Ward, Mary
|
DCEG (NCI)
|
|
Intervention models for thyroid proliferative disease using a bioactive food comp
|
5R01CA131946-05
|
$300,826
|
$300,826
|
TIWARI, RAJ
|
NEW YORK MEDICAL COLLEGE
|
Total relevant funding to Thyroid for this search: $19,638,769
|